Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC is starting to provide services of developing value dossiers for medical device and IVD companies

Every innovative technology has the challenge to communicate the value to different stakeholders. Why this health care problem is important (mortality, morbidity, impact on quality of life, cost-of-illness)? What are the current treatment options and what are their limitations? What is the size of the population with high unmet need? What is the proposed novel solution? Is it safe and effective? What are the economic consequences to the hospital and health care system? What are the organizational requirements for the introduction of a novel method?

Historically, these questions were answered by separate publications in peer-reviewed journals and marketing materials. However, they are typically not comprehensive enough, lack of important information and too unstructured to support discussion with clinicians, reimbursement authorities and payers.

The modern answer to the challenge of summarizing and presenting the value of the technology is the value dossier. Value dossier is the document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The document is also used as a source for information for any reimbursement-related activities: from supporting local business case to application to national HTA.

There are two formats of the value dossier: early dossier - a relatively short (15-20 pages) documents, based on systematic but limited search with the focus on the key messages and data; core value dossier is more comprehensive document (typically about 60-100 pages plus supplements) that includes more argumentation and more value messages.

MTRC can provide support with development of both early and core value dossiers. Typically, dossier is developed either from a global or European perspective.

Historically, these questions were answered by separate publications in peer-reviewed journals and marketing materials. However, they are typically not comprehensive enough, lack of important information and too unstructured to support discussion with clinicians, reimbursement authorities and payers.

The modern answer to the challenge of summarizing and presenting the value of the technology is the value dossier. Value dossier is the document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The document is also used as a source for information for any reimbursement-related activities: from supporting a local business case to the application to national HTA.

There are two formats of the value dossier: early dossier - a relatively short (15-20 pages) documents, based on systematic but limited search with the focus on the key messages and data; core value dossier is more comprehensive document (typically about 60-100 pages plus supplements) that includes more argumentation and more value messages.

MTRC can provide support with the development of both early and core value dossiers. Typically, dossier is developed either from a global or European perspective.

Learn more here: https://services.mtrconsult.com/valuedossier